CDKN2A and neuroblastoma: In this study, NB cell lines with distinct morphological phenotypes (i.e. LAN-1: adrenergic; CHLA-90: mesenchymal-like; CHLA-172: mesenchymal) showed CDK4 amplification and partial CDKN2A loss.